Upcoming FREE SC MAT ACCESS Waiver Training

Our job at SC MAT ACCESS is to facilitate your access to training. In addition to the training resources listed above, our team of experts is offering a series of in-person waiver trainings. These trainings will be free of charge and open to any waiver-eligible provider. To register, Contact Us. A list of upcoming trainings is provided below:

Upcoming Free Waiver Training

Friday, February 21, 2020 From 8:30 AM To 5:30 PM at wingate by wyndham, 108 sALUDA POINTE CT. LEXINGTON, SC 29072

CONTACT ROBERTA BRANECK AT RBRANECK@DAODAS.SC.GOV TO REGISTER



PAST TRAININGS

Friday, November 8, 2019 From 8:30 am to 5:30 pm at Wingate by Wyndham, Lexington, SC:

Contact Roberta Braneck at rbraneck@daodas.sc.gov to register

Monday, November 18, 2019 from 9:00 am - 5:00 Pm at MUSC, charleston, SC:

Contact Suzanne Lane at lanesu@musc.edu to register

FRIDAY, JULY 12 FROM 8:30AM TO 4:30PM AT PALmetto health family residency program, richland, sc

FRIDAY, February 8 from 8:30AM to 4:30pm at Aiken-Barnwell Mental Health Center in Aiken, SC

Friday, february 8 from 8:30AM to 4:30PM at Anderson/Oconee Behavioral Health Services

*Live Stream EvenT*

Friday, April 12 From 8:30AM to 4:30PM at USC Beaufort-Hilton Head Island Campus

Don’t see a date that works for you? Have a large group or practice that wants to schedule a private waiver training? Need additional support? Please connect with us either through our Contact Us form or by emailing our program coordinator, Rachel Grater (grater@musc.edu).

What are the potential benefits of becoming a MAT provider?

South Carolina is in the midst of an opioid epidemic. From addiction to overdose, the impact of opioid abuse is far reaching and can be devastating.

If you are an active primary care provider in South Carolina, there is a reasonable likelihood that the opioid epidemic has touched the lives of one or more of your patients.

Becoming a MAT provider does not have to mean refocusing your practice into a drug treatment facility. What it does mean is that you will be trained, equipped, and ready to offer evidence-based treatment options to your patients who may be struggling with opioid addiction.

Providing MAT can be a cost-effective addition to the existing array of services you provide your patients.

Witnessing the life-saving effects that this evidence-based treatment for opioid addiction can have in the lives of your patients can be the biggest benefit of all.

How do I become a MAT provider?

Currently, three provider classes are eligible to become DATA 2000 waivered to prescribe buprenorphine in the context of MAT. Click below for more information regarding eligibility and training requirements for each:

Under the Drug Addiction Treatment Act of 2000 (DATA 2000), qualified physicians may apply for waivers to treat opioid dependency with approved buprenorphine products in any settings in which they are qualified to practice, including a office, community hospital, health department, or correctional facility.

A “qualifying physician” is one who is:

  • Licensed under state law
  • Registered with the Drug Enforcement Agency to dispense controlled substances
  • Required to treat no more than 30 patients at a time within the first year
  • Qualified by training and/or certification
  • Capable of referring patients to (or providing) counselingand other services

To qualify for a waiver, a licensed physician (M.D. or D.O.) must meet any one or more of the following criteria and provide supporting documentation for all that apply:

  • Hold a subspecialty board certification in addiction psychiatry from the American Board of Medical Specialties
  • Hold an addiction certification from the American Society of Addiction Medicine (ASAM)
  • Hold a subspecialty board certification in addiction medicine from the American Osteopathic Association
  • Have completed the required 8 hours of training for the treatment and management of patients with opioid use disorders (see training table below)
  • Have participated as an investigator in one or more clinical trials leading to the approval of a narcotic medication in Schedule III, IV, or V for maintenance or detoxification.
  • Have other trainingor experience that the state medical licensing board considers a demonstration of the physician’s ability to treat and manage patients with opioid dependency
  • Have completed other training or experience that HHS considers a demonstration of the physician’sability to treat and manage patients with opioid dependency.

The Comprehensive Addiction and Recovery Act (CARA) wassigned into law in July, 2016. One of CARA’s provisions was to expand access to MAT by extending the privilege of prescribing buprenorphine in office-based settings to qualifying nurse practitioners (NPs) and physician assistants (PAs) until October 1, 2021.

  • Complete no fewer than 24 hours of initial training provided by one of the following organizations: American Society of Addiction Medicine, American Academy of Addiction Psychiatry, American Medical Association, American Osteopathic Association, American Nurses Credentialing Center, American Psychiatric Association, American Association of Nurse Practitioners, American Academy of Physician Assistants, or any other organization that the Secretary of Health and Human Services determines is appropriate.
  • NPs and PAs may take the 8-hour DATA Waiver course for the treatment of opioid use disorder, provided for free by the Providers’ Clinical Support System for Medication Assisted Treatment (PCSS-MAT).
  • The additional 16 hours of training is now also available free of charge at the PCSS-MAT website.

Once SAMHSA verifies that the background of a provider is correct and valid, the DEA assigns the waivered provider a special identification number. DEA regulations require this identification number and the provider’s regular DEA registration number on all buprenorphine prescriptions for opioid dependence treatment.

Several resources exist to help providers access the training required for DATA 2000/CARA eligibility. We have summarized these training opportunities in the table below. You can visit the website for any one of these training programs by clicking the training title on the left-hand column of the table.

OrganizationCostLocationCredit HoursCMEProfessions
Americans Academy of Addiction Psychiatry - CURRENTLY UNAVAILABLE DUE TO UPDATING


8 AMA PRA Category 1
MD, DO
ASAM Buprenorphine Course for Office-Based Treatment of Opioid Use Disorders
None for Online/Live Varies
Live In-Person & Web-Based
8/Additional 16
8 AMA PRA Category 1 orup to 24 AAPA Category 1 orup to 24 AANP CE
MD, DO, NP, PA
Providers Clinical Support System for Medication Assisted Treatment Self-Study at the American Osteopathic Academy of Addiction Medicine
None
Live Online & Web-Based
8
4.25 -8 AMA PRA Category 1/ 8 AAFP/ 8 AOA Category 1-A
MD, DO, NP, PA
Providers’ Clinical Support System for Medication Assisted Treatment
None
Live & Web-Based
8/Additional 16
8 AMA PRA Category 1
MD, DO, NP, PA

Once you have completed your waiver training, registered with SAMHSA, and received your DEA special identification number, you are ready to begin seeing patients. Patient limits can be increased annually through completion of a brief additional application process. Yearly patient limits are as follows:

  • Year 1: Maximum of 30 MAT patients
  • Year 2: Maximum of 100 MAT patients
  • Year 3: Maximum of 275 patients